Search

Author/Creator Dong, Xiaowei

12. Integration of comprehensive genomic profiling, tumor mutational burden, and PD‐L1 expression to identify novel biomarkers of immunotherapy in non‐small cell lung cancer. (2nd March 2021)

Authors:
Shi, Yunfei; Lei, Youming; Liu, Li; Zhang, Shiyue; Wang, Wenjing; Zhao, Juan; Zhao, Songhui; Dong, Xiaowei; Yao, Ming; Wang, Kai; Zhou, Qing
Journal:
Cancer medicine
Issue:
Volume 10:Number 7(2021)
Page Start:
2216
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. NFE2L2/KEAP1 Mutations Correlate with Higher Tumor Mutational Burden Value/PD‐L1 Expression and Potentiate Improved Clinical Outcome with Immunotherapy. (28th April 2020)

Authors:
Xu, Xian; Yang, Yang; Liu, Xiaoyan; Cao, Na; Zhang, Peng; Zhao, Songhui; Chen, Donglin; Li, Li; He, Yong; Dong, Xiaowei; Wang, Kai; Lin, Hanqing; Mao, Naiquan; Liu, Lingxiang
Journal:
Oncologist
Issue:
Volume 25:Number 6(2020)
Page Start:
e955
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Programmed cell death‐ligand 1 expression in hepatocellular carcinoma and its correlation with clinicopathological characteristics. Issue 9 (10th March 2021)

Authors:
Mou, Haibo; Yang, Qiu‐an; Yu, Lanfang; Wang, Ting; Liu, Kui; Shen, Rong; Pan, Xuedong; Dai, Yi; Wan, Qing; Zhou, Fangling; Qian, Lili; Chen, Donglin; Yau, Thomas; Dong, Xiaowei; Wang, Xuemei; Wang, Shuang
Journal:
Journal of gastroenterology and hepatology
Issue:
Volume 36:Issue 9(2021)
Page Start:
2601
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗